Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-α production, inhibit sentrin/SUMO-specific protease 1 enzymatic activity
Authors:
- 1 September 2016
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 26 (17) , 4237-4240
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Tokyo University of Agriculture
This publication has 28 references indexed in Scilit:
- Advances in the development of SUMO specific protease (SENP) inhibitorsComputational and Structural Biotechnology Journal, 2015
- Emerging roles of the SUMO pathway in developmentCellular and Molecular Life Sciences, 2011
- SUMOylation Regulates Insulin Exocytosis Downstream of Secretory Granule Docking in Rodents and HumansDiabetes, 2011
- SUMOylation and De-SUMOylation: Wrestling with Life's ProcessesJournal of Biological Chemistry, 2009
- Nucleolar protein B23/nucleophosmin regulates the vertebrate SUMO pathway through SENP3 and SENP5 proteasesJournal of Cell Biology, 2008
- Emerging roles of the SUMO pathway in mitosisCell Division, 2008
- Vialinin A, a Novel Potent Inhibitor of TNF-.ALPHA. Production from RBL-2H3 CellsBiological and Pharmaceutical Bulletin, 2008
- Sumoylation regulates diverse biological processesCellular and Molecular Life Sciences, 2007
- Small Ubiquitin-related Modifier (SUMO)-specific ProteasesJournal of Biological Chemistry, 2007
- Vialinin A, a Novel 2,2-Diphenyl-1-picrylhydrazyl (DPPH) Radical Scavenger from an Edible Mushroom in ChinaBioscience, Biotechnology, and Biochemistry, 2005